What Is MLR Review Readiness? The Pre-Submission Checklist

Two teams submit the same promotional one-pager. One clears MLR in a single round. The other takes six weeks and eleven versions. The copy is identical. The difference is entirely in the state each piece was in when it arrived.

That state has a name, and it is the single strongest predictor of how long review takes: MLR review readiness.

Most teams try to speed up MLR by pushing on the review itself, adding reviewers, escalating, chasing sign-offs. It rarely works, because review is not usually the bottleneck. What arrives for review is. This page defines review readiness, gives you the eight-point checklist to test a submission against, and covers where automation genuinely helps before the piece is ever submitted.

What is MLR review readiness?

MLR review readiness is the degree to which a submission can be verified rather than reconstructed. A review-ready piece lets a reviewer confirm each claim against its source in seconds. A piece that is not review-ready forces the reviewer to do the author's work first: hunting through PDFs for the sentence that supports a claim, guessing which study a number came from, checking whether a reused claim still means what it meant in its original context.

That distinction is measurable. In a 2025 analysis of medical reviewers, the time to review a single promotional one-pager ranged from under an hour to more than five (N=192). The deciding factor was not the length of the piece or the complexity of the science. It was whether the claims had been pre-aligned and whether the references actually supported them.

The same one-page leave-behind is a ten-minute job or a lost weekend, depending entirely on who prepared it and how.

Why readiness beats every other lever

Reviewers are already saturated. In a 2024 promotional-review benchmark from Canopy, roughly two out of three reviewers spend at least 15% of their working week on promotional review, and about one in three spend 25% or more. Adding review capacity to a system fed by unready submissions just moves the queue.

And capacity is the lever most teams reach for anyway. In a 2024 audience poll run by Impatient Health, when volume spiked, 53% said they simply absorb the extra workload with existing staff. Only 5% had invested in technology to handle the surge.

Readiness is the cheaper lever because it attacks rework at the source. A piece that arrives verifiable does not generate the comment that triggers the revision that restarts the clock for all three functions. We trace how that loop compounds in the MLR review process.

The eight-point pre-submission checklist

Run a piece against these before it goes into Veeva Vault PromoMats, Aprimo, or Vodori. Each one maps to a failure mode that reliably produces a review round.

1. Every claim is linked and anchored to its exact source line

Not "cited on the back page." Anchored: each claim tied to the specific page and, ideally, the highlighted sentence that supports it. This is the highest-leverage item on the list, and the one most often skipped. Many reviewers simply refuse a piece without it. See linking and anchoring for how to prepare a reference pack properly.

2. Every claim that needs a reference has one

Not every sentence needs a citation, and over-referencing creates its own review noise. The test is whether the sentence makes a factual assertion a regulator could challenge. What actually needs a reference walks through where the line sits.

3. Every reference actually exists

Obvious, until a general-purpose AI assistant is involved. Tools like ChatGPT and Copilot will confidently produce citations to papers that were never written. A fabricated reference in a promotional submission is exactly the error the whole process exists to catch. Verify each one against PubMed or the source itself; see why AI invents citations.

4. Every reference supports the claim as worded

A real paper attached to a claim it does not support is still a finding. Check population, comparator, endpoint, and context. An abstract is not the primary data. A subgroup result is not the primary endpoint.

5. No claim drift from the approved wording

The quiet addition of "unique," "first-line," or "best" turns a previously approved claim into a new one that needs fresh substantiation. Compare against the approved label and the original claim wording, not against the last deck it appeared in. Garbage in, compliance out covers how drift accumulates.

6. Reused claims came from the claims library, not an old file

If a claim was lifted from a prior asset rather than the core-claims library, you have inherited whatever was wrong with it, plus any context it has since lost.

7. Prior rejections have been checked

The most avoidable round is re-submitting wording that was already rejected once. If your team does not keep a record of what was rejected and why, this is where to start building one.

8. References are formatted consistently

The lowest-stakes item, and still worth doing: inconsistent citation formatting generates its own review comments. Whether your SOP mandates AMA or the Vancouver/ICMJE family, apply it uniformly (here is how those styles actually relate). Our free AMA citation generator turns a PubMed record into a clean reference in one paste.

Where automation actually helps before MLR

Practitioners are specific about this, and their instinct is worth following. In the Impatient Health polling, asked where AI offers the most genuine near-term value in MLR, the top two answers were speeding up initial data gathering and fact-checking (27%) and identifying inconsistencies or missing information in materials (27%). Both are narrow, assistive, pre-submission tasks.

Asked in a related poll which AI claim is most overstated, the top answer, again 27%, was "speeding up compliance and regulatory processes."

Read those two results together and the conclusion is clear: automate the readiness work, not the review decision. Checking whether a reference exists, whether it supports the claim, and whether the claim drifted are mechanical, high-volume, error-prone tasks that a machine does well and a tired human does badly at 6pm. Deciding whether a piece is compliant is judgment, and it stays with the reviewer. When asked who is responsible if an AI-assisted piece causes a compliance breach, 39% of those polled pointed to the human who performed the final review.

This is the layer PharmaText.ai operates in. It is not a replacement for Veeva Vault PromoMats or any other review platform, and it does not route, approve, or sign anything off (here is the full comparison). It runs before the upload: you write the copy, it checks every claim against your uploaded source PDFs, flags anything unsupported, mis-sourced, or inconsistent with the label, and anchors what passes to the exact supporting line. What reaches MLR is already verifiable.

Plans start at $69/month with self-serve checkout, so you can test it on a real piece before involving anyone else. See how it works.

MLR review readiness FAQ

What does MLR review readiness mean? MLR review readiness is the degree to which a submission can be verified rather than reconstructed. In a review-ready piece, every claim is linked and anchored to the exact line of the source that supports it, so a reviewer confirms it in seconds instead of hunting for the evidence themselves.

How do I know if a piece is ready for MLR submission? Test it against eight points: every claim linked and anchored, every claim that needs a reference has one, every reference exists, every reference supports the claim as worded, no drift from approved wording, reused claims came from the claims library, prior rejections checked, and references formatted consistently.

Does review readiness actually shorten MLR timelines? It is the strongest single factor. A 2025 analysis of 192 medical reviewers found the time to review one promotional one-pager ranged from under an hour to more than five, and the deciding variable was whether claims had been pre-aligned and whether references supported them, not the length or complexity of the piece.

Can AI make a submission MLR-ready? It can do the mechanical parts well: confirming a reference exists, checking that it supports the claim as worded, spotting claim drift, and anchoring citations to source lines. It should not make the compliance decision. Practitioners consistently rank AI's value in MLR as assistive fact-checking, and 39% hold the human who performed the final review accountable for an AI-assisted breach.

What is pre-MLR review? Pre-MLR review is the readiness work done before a piece is formally submitted: verifying claims against sources, anchoring citations, and resolving medical and legal concerns on a draft rather than on a designed, laid-out asset. It is where most avoidable review rounds are eliminated.

Related: see the MLR review process, what MLR review is, and retrofitting anchoring into already-approved materials.

Sources: promotional-review time data from the Medical Affairs workload overview by Maaike Addicks, medicalaffairs.nl (2025); reviewer workload data presented at a 2024 industry webinar by Canopy; AI-value, surge-capacity and accountability polling from 2024 industry webinars by Impatient Health. The Canopy and Impatient Health underlying reports are not publicly available.